Results 161 to 170 of about 15,676,085 (372)

Effects of tetrahedral framework nucleic acid/wogonin complexes on osteoarthritis [PDF]

, 2020
Sirong Shi, Chen Yang, Taoran Tian, Songhang Li, Shiyu Lin, Yuxin Zhang, Xiaoru Shao, Tao Zhang, Yunfeng Lin, Xiaoxiao Cai   +9 more
openalex   +1 more source

Block2: A comprehensive open source framework to develop and apply state-of-the-art DMRG algorithms in electronic structure and beyond [PDF]

, 2023
Huanchen Zhai, Henrik R. Larsson, Seunghoon Lee, Zhi‐Hao Cui, Tianyu Zhu, Chong Sun, Linqing Peng, Ruojing Peng, Ke Liao, Johannes Tölle, Junjie Yang, Shuoxue Li, Garnet Kin‐Lic Chan   +12 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Registration with the Point Cloud Library: A Modular Framework for Aligning in 3-D

, 2015
Dirk Holz, Alexandru Eugen Ichim, Federico Tombari, Radu Bogdan Rusu, Sven Behnke   +4 more
openalex   +2 more sources

Vapor-deposited zeolitic imidazolate frameworks as gap-filling ultra-low-k dielectrics [PDF]

, 2019
Mikhail Krishtab, Ivo Stassen, Timothée Stassin, Alexander John Cruz, Oguzhan Orkut Okudur, Silvia Armini, Chris Wilson, Stefan De Gendt, Rob Ameloot   +8 more
openalex   +1 more source

Actions on sustainable food production and consumption for the post-2020 global biodiversity framework [PDF]

, 2021
Izabela Delabre, Lily O. Rodríguez, Joanna Miller Smallwood, Jörn P. W. Scharlemann, Joseph Alcamo, Alexander S. Antonarakis, Pedram Rowhani, Richard J. Hazell, Dag L. Aksnes, Patricia Balvanera, Carolyn J. Lundquist, Charlotte Gresham, Anthony Alexander, Nils Chr. Stenseth   +13 more
openalex   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Constructing the international legal framework [PDF]

, 2012
Buck, T, Nicholson, A
core   +1 more source

Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies

, 2019
John M. Carethers, Chyke A. Doubeni
openalex   +2 more sources